Table of Contents
<< Previous Issue | Aug 2013 (Vol: 2013, Issue: 8) | Next Issue >> |
- Section: Joint Venture
-
Fresenius Kabi Expands in Indonesia with Soho Group Joint Venture
- Section: Licensing
-
Ligand Licenses Injectable Formulation of Topiramate to Start-Up CURx
- Section: Mergers & Acquisitions
-
Perrigo Seeks Tax Advantages with Elan Acquisition
- Section: Research & Development
-
Celgene Pays US$100 M for Option to Buy Acetylon and Partners with Array BioPharma
-
Bayer Expands Research in Cancer Immunotherapy with Compugen Pact
- Section: Technology Access
-
Adimab Strikes its First Technology Transfer Deals with GSK and Biogen Idec